Responses
Immunotherapy biomarkers
Original research
Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
